BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19796917)

  • 1. A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes.
    Scheuplein F; Rissiek B; Driver JP; Chen YG; Koch-Nolte F; Serreze DV
    J Autoimmun; 2010 Mar; 34(2):145-54. PubMed ID: 19796917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion.
    Chen J; Chen YG; Reifsnyder PC; Schott WH; Lee CH; Osborne M; Scheuplein F; Haag F; Koch-Nolte F; Serreze DV; Leiter EH
    J Immunol; 2006 Apr; 176(8):4590-9. PubMed ID: 16585549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice.
    Chen YG; Scheuplein F; Driver JP; Hewes AA; Reifsnyder PC; Leiter EH; Serreze DV
    J Immunol; 2011 Apr; 186(7):4278-84. PubMed ID: 21357538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice.
    Ablamunits V; Bridgett M; Duffy T; Haag F; Nissen M; Koch-Nolte F; Leiter H
    Diabetologia; 2001 Jul; 44(7):848-58. PubMed ID: 11508269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T cells in nonobese diabetic mice.
    Chen YG; Chen J; Osborne MA; Chapman HD; Besra GS; Porcelli SA; Leiter EH; Wilson SB; Serreze DV
    J Immunol; 2006 Sep; 177(5):2939-47. PubMed ID: 16920929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo.
    Adriouch S; Hubert S; Pechberty S; Koch-Nolte F; Haag F; Seman M
    J Immunol; 2007 Jul; 179(1):186-94. PubMed ID: 17579037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.
    Krebs C; Adriouch S; Braasch F; Koestner W; Leiter EH; Seman M; Lund FE; Oppenheimer N; Haag F; Koch-Nolte F
    J Immunol; 2005 Mar; 174(6):3298-305. PubMed ID: 15749861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic overexpression of toxin-related ecto-ADP-ribosyltransferase ART2.2 sensitizes T cells but not B cells to NAD-induced cell death.
    Bannas P; Scheuplein F; Well L; Hermans-Borgmeyer I; Haag F; Koch-Nolte F
    Mol Immunol; 2011 Sep; 48(15-16):1762-70. PubMed ID: 21641039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.
    Blumenfeld HJ; Tohn R; Haeryfar SM; Liu Y; Savage PB; Delovitch TL
    Clin Exp Immunol; 2011 Oct; 166(1):121-33. PubMed ID: 21910729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.
    Ohlrogge W; Haag F; Löhler J; Seman M; Littman DR; Killeen N; Koch-Nolte F
    Mol Cell Biol; 2002 Nov; 22(21):7535-42. PubMed ID: 12370300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ART2, a T cell surface mono-ADP-ribosyltransferase, generates extracellular poly(ADP-ribose).
    Morrison AR; Moss J; Stevens LA; Evans JE; Farrell C; Merithew E; Lambright DG; Greiner DL; Mordes JP; Rossini AA; Bortell R
    J Biol Chem; 2006 Nov; 281(44):33363-72. PubMed ID: 16931513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.
    Tohn R; Blumenfeld H; Haeryfar SM; Veerapen N; Besra GS; Porcelli SA; Delovitch TL
    Clin Exp Immunol; 2011 Apr; 164(1):26-41. PubMed ID: 21361909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice.
    Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
    J Cell Mol Med; 2019 Feb; 23(2):1072-1085. PubMed ID: 30421497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.
    Scheuplein F; Lamont DJ; Poynter ME; Boyson JE; Serreze D; Lundblad LK; Mashal R; Schaub R
    PLoS One; 2015; 10(10):e0140729. PubMed ID: 26474487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Art2+ cells but not soluble Art2 protein correlate with expression of autoimmune diabetes in the BB rat.
    Bortel R; Waite DJ; Whalen BJ; Todd D; Leif JH; Lesma E; Moss J; Mordes JP; Rossini AA; Greiner DL
    Autoimmunity; 2001 May; 33(3):199-211. PubMed ID: 11683379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.